ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
21.46 USD
-0.52 (-2.37%)
21.46 USD
0 (0%)
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 184 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. ENOV scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
- In the past year ENOV was profitable.
- ENOV had a positive operating cash flow in the past year.
- In multiple years ENOV reported negative net income over the last 5 years.
- Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
- ENOV has a Return On Assets (-30.84%) which is comparable to the rest of the industry.
- ENOV has a Return On Equity (-67.66%) which is comparable to the rest of the industry.
- Looking at the Return On Invested Capital, with a value of 0.12%, ENOV is in the better half of the industry, outperforming 64.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Operating Margin value of 0.25%, ENOV is doing good in the industry, outperforming 64.67% of the companies in the same industry.
- In the last couple of years the Operating Margin of ENOV has declined.
- ENOV has a Gross Margin (57.19%) which is in line with its industry peers.
- ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
- The number of shares outstanding for ENOV has been increased compared to 1 year ago.
- Compared to 5 years ago, ENOV has more shares outstanding
- The debt/assets ratio for ENOV is higher compared to a year ago.
2.2 Solvency
- ENOV has an Altman-Z score of 0.70. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
- ENOV has a Altman-Z score (0.70) which is in line with its industry peers.
- ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
- ENOV has a Debt to FCF ratio of 59.72. This is in the better half of the industry: ENOV outperforms 66.85% of its industry peers.
- ENOV has a Debt/Equity ratio of 0.66. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.66, ENOV is not doing good in the industry: 64.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.7 |
ROIC/WACC0.01
WACC9.66%
2.3 Liquidity
- ENOV has a Current Ratio of 2.22. This indicates that ENOV is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.22, ENOV is in line with its industry, outperforming 43.48% of the companies in the same industry.
- ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.16, ENOV is doing worse than 69.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
- ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
- Measured over the past years, ENOV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.18% on average per year.
- ENOV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.57%.
- ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
- The Earnings Per Share is expected to grow by 23.19% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 8.87% on average over the next years. This is quite good.
EPS Next Y14.57%
EPS Next 2Y11.17%
EPS Next 3Y11.67%
EPS Next 5Y23.19%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 6.44, which indicates a rather cheap valuation of ENOV.
- ENOV's Price/Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 98.37% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 28.60. ENOV is valued rather cheaply when compared to this.
- A Price/Forward Earnings ratio of 6.14 indicates a rather cheap valuation of ENOV.
- Based on the Price/Forward Earnings ratio, ENOV is valued cheaply inside the industry as 98.91% of the companies are valued more expensively.
- The average S&P500 Price/Forward Earnings ratio is at 25.83. ENOV is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.44 | ||
| Fwd PE | 6.14 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 93.48% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, ENOV is valued a bit cheaper than 72.83% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.91 | ||
| EV/EBITDA | 8.58 |
4.3 Compensation for Growth
- ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y11.17%
EPS Next 3Y11.67%
5. Dividend
5.1 Amount
- No dividends for ENOV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
What is the valuation status of ENOVIS CORP (ENOV) stock?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.